MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..19 of 19 - per page Previous page
Order by
25mg dosage strenght for the OTC market More
12,5 mg diclofenac K film coated immediate release tablets (OTC) More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
New pharmaceutical compositions for oral use containing diclofenac together with alkali metal carbonates and bicarbonates and particular flavouring substances. More
Anti-inflammatory drugs are commonly spread and used to treat pain, arthrosis, asthma or psoriasis. Our laboratory has developed a new molecule against these diseases with some interesting results. More
Compositions and methods of use of A2 adenosine receptor (AR) agonists for treating conditions modulated by A2A and A2B ARs including myocardial ischemia, reperfusion injury, cystic fibrosis, erectile dysfunction, inflammation, restenosis and septic shock More
A method and composition for inhibiting or treating symptoms of inflammatory demyelination or inflammation associated with autoimmune disorders. More
This invention concerns the design of an ultrasound transducer mounting assembly incorporating a novel tracking device. More
This invention concerns the discovery of novel autoantigenic peptides useful for the diagnosis and treatment of rheumatoid arthritis. More
Displaying 11..19 of 19 - per page Previous page
Order by

Your selection

Therapeutic target
Central Nervous System del
Pain del
Pain, inflammatory del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us